# VANOS Cream and Skin Barrier Function

> **NCT00819507** · PHASE4 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 25 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Fluocinonide

## Key facts

- **NCT ID:** NCT00819507
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-01
- **Final completion:** 2010-06-21
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00819507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00819507, "VANOS Cream and Skin Barrier Function". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00819507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*